Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ITAX | P20702 | Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | |||
| ITPI2 | P28290 | Protein ITPRID2 (Cleavage signal-1 protein) (CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2) | Plasma proteinsPredicted intracellular proteins | Other mediation | 2 | 0.53 | ||||
| JUPI2 | Q9H910 | Jupiter microtubule associated homolog 2 (Hematological and neurological expressed 1-like protein) (HN1-like protein) | Predicted intracellular proteins | Receptor-signaling mediation | 2 | 0.53 | ||||
| KANK1 | Q14678 | KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) | Disease related genesHuman disease related genesPlasma proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | ||||
| KANL2 | Q9H9L4 | KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog) | Essential proteinsPredicted intracellular proteins | Other mediation | 2 | 0.53 | ||||
| KC1D | P48730 | Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) | Disease related genesEnzymesHuman disease related genes | Mature B-cell leukaemiaPancreatic cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.53 | |||
| KCNH8 | Q96L42 | Voltage-gated delayed rectifier potassium channel KCNH8 (ELK1) (hElk-1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Potassium voltage-gated channel subfamily H member 8) (Voltage-gated potassium channel subunit Kv12.1) | Predicted membrane proteinsVoltage-gated ion channels | 6 | Clinical-translation mediationFusion and delivery mediation | 2 | 0.53 | |||
| KCNKH | Q96T54 | Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2) (TALK-2) | Predicted membrane proteinsTransportersVoltage-gated ion channels | 4 | Fusion and delivery mediation | 2 | 0.53 | |||
| KCNU1 | A8MYU2 | Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3) | 7 | Fusion and delivery mediation | 2 | 0.53 | ||||
| KI3L1 | P43629 | Killer cell immunoglobulin-like receptor 3DL1 (CD158 antigen-like family member E) (HLA-BW4-specific inhibitory NK cell receptor) (Natural killer-associated transcript 3) (NKAT-3) (p70 natural killer cell receptor clones CL-2/CL-11) (p70 NK receptor CL-2/CL-11) (CD antigen CD158e) | 1 | Immune mediation | 2 | 0.53 |